Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000902601 | SCV001047031 | likely benign | not provided | 2018-08-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004028530 | SCV003727424 | uncertain significance | not specified | 2021-07-13 | criteria provided, single submitter | clinical testing | The c.622G>A (p.V208I) alteration is located in exon 4 (coding exon 4) of the KIAA1210 gene. This alteration results from a G to A substitution at nucleotide position 622, causing the valine (V) at amino acid position 208 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000902601 | SCV005206731 | likely benign | not provided | criteria provided, single submitter | not provided |